Isai H, Sato K, Kasai Y, Kawamura A, Nakao A
Hokkaido Igaku Zasshi. 1983 Jan;58(1):74-8.
With the advance of hemodialysis, it has become apparent that immunity, especially cellular, is lowered in patients on maintenance hemodialysis. We administered Venoglobulin I (VGI) to the patients on maintenance hemodialysis to study the change in the immune system and the episodes of infection. VGI was administered to twelve cases, eight males and four females, and their mean period of hemodialysis was three years. Administration of VGI started in February 1981 an mean duration of administration was 7.8 months. As a rule, 2.5g of VGI was administered every 20 days. Counts of white blood cells, lymphocytes, T cells and B cells were measured every two months. The cases were divided into two groups according to the duration of hemodialysis: Group A, less than a year and Group B, more than a year and a month. Results and conclusions 1) VGI increases the lymphocytes and T cell counts in Group B to suggest the improvement of cellular immunity. 2) In Group A, lymphocytes and T cell counts were decreased because the effects of VGI were overcome by the effect of hemodialysis to distort the immune system. 3) The magnitude of effects of VGI was proportional to the period of administration. The effect appeared at least within eight months, and once it appeared, it kept stable level. 4) There had been no episodes of infection during the period of study. 5) With these results, it was indicated that administration of VGI to the patients on maintenance hemodialysis was useful because VGI could support their lowered cellular immunity to some extent.
随着血液透析技术的进步,维持性血液透析患者免疫力降低,尤其是细胞免疫功能降低已变得很明显。我们对维持性血液透析患者给予静脉注射免疫球蛋白(VGI),以研究免疫系统的变化及感染发作情况。对12例患者给予VGI,其中男性8例,女性4例,他们的平均血液透析时间为3年。VGI给药始于1981年2月,平均给药持续时间为7.8个月。通常每20天给予2.5g VGI。每两个月检测白细胞、淋巴细胞、T细胞和B细胞计数。根据血液透析时间将病例分为两组:A组,透析时间少于1年;B组,透析时间超过1年零1个月。结果与结论:1)VGI使B组淋巴细胞和T细胞计数增加,提示细胞免疫功能改善。2)在A组,淋巴细胞和T细胞计数减少,因为血液透析的作用抵消了VGI的作用,从而扭曲了免疫系统。3)VGI的作用强度与给药时间成正比。至少在8个月内出现作用,一旦出现,便保持稳定水平。4)研究期间未发生感染发作。5)基于这些结果表明,对维持性血液透析患者给予VGI是有益的,因为VGI能在一定程度上支持其降低的细胞免疫功能。